You are here

News

2016

Icla da Silva Foundation logo
Jun 2016   The Icla da Silva Foundation is the largest recruitment center for the Be The Match® Registry in the United States. It recruits over 38,000 new potential bone marrow donors every year, with a strong focus on minority communities. The Icla da Silva Foundation also distributes cord blood educational brochures from the Parent’s Guide to Cord Blood Foundation that are available in over a dozen languages.
Nick Walker, PhD
Jun 2016   A rare subset of the human population possess a natural mutation which prevents the HIV virus from entering their cells. Dr. Walker proposes to use gene editing to create a bank of cord blood stem cells that carry the mutation for HIV protection and can provide life-saving transplants for AIDS patients.
Perinatal Stem Cell Society
May 2016   Editorial from Kyle Cetrulo of the Perinatal Stem Cell Society: I strongly urge the cord blood banking community to rally behind a proposed bill currently in the US congress call the “Reliable and Effective Growth for Regenerative Health Options that Improve Wellness”, or the REGROW Act. There needs to be a regulatory paradigm shift that allows patients access to autologous cellular therapies. As we stand today, it will be very difficult for a private cord blood banking clients to access treatment to use their own child’s banked cord blood to treat their child’s cerebral palsy in the United States - outside of future clinical trials - unless the regulatory structure changes.
Taburit
May 2016   Interview with Prof. Joanne Kurtzberg that originally appeared in the Israeli newspaper Yediot Aharonot Saturday Supplement 6 April 2016. Reported by Smadar Shir and translated by Tali Pelz.
AutoImmune Diseases can effect any organ in the body
Apr 2016   To date, most stem cell therapies for autoimmune diseases have been autologous stem cell transplants (AHSCT). Exciting results have been reported from clinical trials for Multiple Sclerosis (MS). In most trials, roughly half of patients who receive AHSCT for MS see the disease progression stop. Transplant response is better for patients who have a shorter history of illness, with some reporting dramatic improvements. Today, the majority of patients in cell trials for autoimmune diseases receive infusions of mesenchymal stem cells (MSC). Therapy with MSC enables MS patients to have improved disability scores without undergoing chemotherapy.
Number of patients enrolled in clinical trials per autoimmune diagnosis
Apr 2016   We are collaborating on a project to compile all cell therapy clinical trials registered worldwide from 2011 through 2015. In this article we have prepared two figures to illustrate the importance of cell therapy clinical trials for autoimmune diseases and the variety of cell types currently in clinical trials for these diagnoses.
Operation Save Hepsi
Apr 2016   Hepsi Zsoldos received the world's first cord blood transplant for the auto-immune disease Rheumatoid Arthritis. Her sister Carolyn tells Hepsi's story and appeals to expectant mothers to donate their cord blood, because "The ripples you make with even one donation can affect people in ways you could never imagine."
Cell Care
Mar 2016   Australians have launched their first clinical trial of cord blood therapy for cerebral palsy, which is the most common disability of childhood in Australia. Now therapy is available with cord blood stem cells from a sibling that is a perfect match. 
Judge Carl Fox
Feb 2016   Carl Fox was a North Carolina Superior Court Judge in spring 2015 when he learned that he needed a stem cell transplant from a donor. But none of the 13.5 million people on the US national registry of adult donors was a match. Thus began the "Save The Fox" campaign of running donor drives. It is a classic story of a community coming together, and also of a devoted nurse who would not take no for an answer. Today Judge Fox is recovering from a double cord blood transplant, but Save The Fox continues to register more donors, especially African Americans who have the hardest time finding a match.
Royan patient Karen
Feb 2016   Karen is a 6-year old boy who suffered from bone marrow failure and needed a stem cell transplant to survive. Great amounts of time and effort were spared to find a matching bone marrow donor for Karen, but all the efforts were in vain and not even a single match could be found. Since his birth, Karen’s own umbilical cord blood had been banked at Royan Stem Cell Technology Company. Karen became the 12th child in the world to receive an autologous transplant of his own cord blood stem cells for Aplastic Anemia, the first such case in Iran and all of the Middle East nations. This transplantation surgery was successfully performed in a fruitful collaboration of Royan Stem Cell Technology Company and Ali Asghar Hospital, under the supervision of Dr. Bahoosh.